Part 314—Applications for FDA Approval to Market a New Drug

1. CFR
2. ›
3. Title 21
4. ›
5. Chapter I
6. ›
7. Part 314

Subparts

• A
  Subpart A—General Provisions Sections 314.1–314.3
• B
  Subpart B—Applications Sections 314.50–314.90
• C
  Subpart C—Abbreviated Applications Sections 314.92–314.99
• D
  Subpart D—FDA Action on Applications and Abbreviated Applications Sections 314.100–314.170
• E
  Subpart E—Hearing Procedures for New Drugs Sections 314.200–314.235
• F
  Subpart F [Reserved]
• G
  Subpart G—Miscellaneous Provisions Sections 314.410–314.445
• H
  Subpart H—Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses Sections 314.500–314.560
• I
  Subpart I—Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible Sections 314.600–314.650